Cargando…
Virus-Like-Vaccines against HIV
Protection against chronic infections has necessitated the development of ever-more potent vaccination tools. HIV seems to be the most challenging foe, with a remarkable, poorly immunogenic and fragile surface glycoprotein and the ability to overpower the cell immune system. Virus-like-particle (VLP...
Autores principales: | Andersson, Anne-Marie C., Schwerdtfeger, Melanie, Holst, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874651/ https://www.ncbi.nlm.nih.gov/pubmed/29439476 http://dx.doi.org/10.3390/vaccines6010010 |
Ejemplares similares
-
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
por: Schwerdtfeger, Melanie, et al.
Publicado: (2019) -
Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection
por: Zhao, Chongbo, et al.
Publicado: (2016) -
Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019) -
Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
por: Mazalovska, Milena, et al.
Publicado: (2020) -
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)